You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
15 December 2021
Johnson & Johnson (J&J) has made changes to its Executive Committee, Moberg Pharma has announced that Peter Wolpert will not stand for re-election as chairman, Blackmores has a new chief financial officer, and Galderma has a new addition to its Advisory Committee.
12 November 2021
Johnson & Johnson (J&J) has announced plans to separate its Consumer Health business into a new publicly-traded company.
2 November 2021
Hygiene and health company Essity has acquired three professional sports-tape brands from Johnson & Johnson (J&J) Consumer for an undisclosed sum.
21 October 2021
The OTC business was the “star” performer for Johnson & Johnson’s (J&J’s) Consumer Health division in the third quarter of 2021, according to Thibaut Mongon, executive vice president of J&J and worldwide head of Consumer Health.
15 October 2021
Johnson & Johnson (J&J) has set up a subsidiary to manage legal claims alleging its talc products caused cancer and has filed for Chapter 11 bankruptcy protection for the new subsidiary called LTL Management.
14 October 2021
Johnson & Johnson (J&J) has announced the retirement of Paul Stoffels, Bayer Consumer Health’s Mike Knowland has joined the Board of the Proprietary Association of Great Britain (PAGB), and Food, Health & Consumer Products of Canada (FHCP) has a new chair.
20 August 2021
Johnson & Johnson (J&J) has announced that Alex Gorsky is stepping down as chief executive officer after nearly a decade in the role. Gorsky said the move was due to “family health reasons”.
23 July 2021
Johnson & Johnson (J&J) expects to see “more normalised growth” in the second half of 2021 as “consumers return to typical usage patterns”.
17 June 2021
The US Consumer Healthcare Products Association (CHPA) has elected Johnson & Johnson’s (J&J’s) Michelle Wang Goodridge as the new chair of its board of directors. She is the industry association’s first female chair.
23 April 2021
Johnson & Johnson (J&J) reported a double-digit drop in its OTC sales during the first quarter of 2021, as the COVID-19 pandemic took its toll in multiple ways.